CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
-0.37%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$1.35B
AUM Growth
-$15.1M
(-1.1%)
Cap. Flow
+$8.93M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
47.37%
Holding
387
New
44
Increased
214
Reduced
84
Closed
22
Top Buys
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$20.5M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$8.46M |
| 3 |
Schwab US Broad Market ETF
SCHB
|
$1.12M |
| 4 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
$885K |
| 5 |
Avantis US Equity ETF
AVUS
|
$880K |
Sector Composition
| 1 | Communication Services | 9.8% |
| 2 | Technology | 7.13% |
| 3 | Financials | 2.52% |
| 4 | Healthcare | 2.27% |
| 5 | Consumer Discretionary | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Intuit
INTU
$188B
| $307K | 0.02% |
+500
| New | +$307K |
|
277
Aflac
AFL
$57.2B
| $306K | 0.02% |
2,755
+377
| +16% | +$41.9K |
|
278
PayPal
PYPL
$65.2B
| $306K | 0.02% |
4,691
-164
| -3% | -$10.7K |
|
279
Southern Company
SO
$101B
| $304K | 0.02% |
+3,301
| New | +$304K |
|
280
Marvell Technology
MRVL
$54.6B
| $302K | 0.02% |
4,901
+374
| +8% | +$23K |
|
281
Cognizant
CTSH
$35.1B
| $300K | 0.02% |
3,923
+947
| +32% | +$72.4K |
|
282
Booking.com
BKNG
$178B
| $300K | 0.02% |
65
+11
| +20% | +$50.7K |
|
283
Otis Worldwide
OTIS
$34.1B
| $299K | 0.02% |
2,895
+246
| +9% | +$25.4K |
|
284
Marathon Petroleum
MPC
$54.8B
| $299K | 0.02% |
2,049
+132
| +7% | +$19.2K |
|
285
Pearson
PSO
$9.15B
| $298K | 0.02% |
18,626
+661
| +4% | +$10.6K |
|
286
Roper Technologies
ROP
$55.8B
| $298K | 0.02% |
505
+95
| +23% | +$56K |
|
287
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$559M
| $297K | 0.02% |
3,970
+8
| +0.2% | +$599 |
|
288
ConocoPhillips
COP
$116B
| $297K | 0.02% |
2,824
-458
| -14% | -$48.1K |
|
289
Affiliated Managers Group
AMG
$6.54B
| $295K | 0.02% |
1,758
+21
| +1% | +$3.53K |
|
290
Biogen
BIIB
$20.6B
| $292K | 0.02% |
2,131
+56
| +3% | +$7.66K |
|
291
Thermo Fisher Scientific
TMO
$186B
| $292K | 0.02% |
586
-187
| -24% | -$93.1K |
|
292
Pfizer
PFE
$141B
| $290K | 0.02% |
11,455
-6,490
| -36% | -$164K |
|
293
Schwab US Dividend Equity ETF
SCHD
$71.8B
| $290K | 0.02% |
10,363
+488
| +5% | +$13.6K |
|
294
Colgate-Palmolive
CL
$68.8B
| $289K | 0.02% |
3,086
+740
| +32% | +$69.3K |
|
295
Public Service Enterprise Group
PEG
$40.5B
| $288K | 0.02% |
3,499
+208
| +6% | +$17.1K |
|
296
Trade Desk
TTD
$25.5B
| $287K | 0.02% |
5,237
-259
| -5% | -$14.2K |
|
297
Genmab
GMAB
$16.9B
| $281K | 0.02% |
+14,361
| New | +$281K |
|
|
B
298
Barrick Mining Corporation
B
$48.5B
| $277K | 0.02% |
+14,243
| New | +$277K |
|
299
National Grid
NGG
$69.6B
| $276K | 0.02% |
+4,330
| New | +$276K |
|
300
Evergy
EVRG
$16.5B
| $275K | 0.02% |
3,990
+257
| +7% | +$17.7K |
|